Issues

 / 

2020

 / 

vol. 18 / 

Issue 1

 



Download the full version of the article (in PDF format)

D. N. Nozdrenko, T. Yu. Matvienko, O. V. Vygovska, V. M. Soroca, K. I. Bogutska, N. E. Nuryshchenko, Yu. I. Prylutskyy, . V. Zholos
«Activation of the Cold and Menthol Receptor TRPM8 Improves Post-Traumatic Recovery of Rat Muscle Soleus During Fullerene Treatment»
205–216 (2020)

PACS numbers: 81.16.Fg, 82.39.Jn, 87.16.dp, 87.16.dr, 87.16.Tb, 87.19.Ff, 87.64.kv

The biomechanical parameters of muscle soleus of rats during the first 3 days of development of the posttraumatic syndrome caused by destruction of muscle cells by means of the mechanical compression are studied. Injections of both C60 fullerene antioxidant and menthol, which is the selective agonist of TRPM8 cold receptors, are used as therapeutic agents. Injections of an aqueous colloidal solution of C60 fullerene (at concentration of 1 mg/kg) into the damaged muscle improve its contractile function by 2530%. Application of combined injections of C60 fullerene and menthol (at concentration of 1 mkg/kg) improve this indicator by an extra 1719%, while stabilizing the decrease in muscle strength observed throughout all experiments. The revealed synergy effect of menthol and aqueous solution of C60 fullerene on posttraumatic process of restitution of skeletal muscle function opens up new prospects for the clinical application of such a combined therapy.

Keywords: muscle soleus, muscular contraction, muscle injury, C60 fullerene, menthol, therapy

https://doi.org/10.15407/nnn.18.01.205

References
1. J. Krustic, . Wasserman, P. N. Keizer, J. R. Morton, and K. F. Preston, Science, 254, No. 5035: 1183 (1991); doi: 10.1126/science.254.5035.1183.
2. D. N. Nozdrenko, K. I. Bogutska, O. Yu. Artemenko, N. Ye. Nurishchenko, and Yu. I. Prylutskyy, Nanosistemi, Nanomateriali, Nanotehnologii, 16, No. 4: 745 (2018).
3. S. Y. Zay, D. A. Zavodovskyi, K. I. Bogutska, D. N. Nozdrenko, and Y. I. Prylutskyy, Fiziol. Zh., 62, No. 3: 66 (2016).
4. A. Dietrich, Cells, 8, No. 5: 413 (2019); doi: 10.3390/cells8050413.
5. D. O. Dryn, M. I. Melnyk, L. Al. Kury, Yu. I. Prylutskyy, U. Ritter, and A. V. Zholos, Cell. Signal., 43: 40 (2018); doi: 10.1016/j.cellsig.2017.12.003.
6. M. I. Melnyk, I. V. Ivanova, D. O. Dryn, Yu. I. Prylutskyy, V. V. Hurmach, M. Platonov, L. T. Al. Kury, U. Ritter, A. I. Soloviev, and A. V. Zholos, Nanomed.: NBM, 19: 1 (2019).
7. C. Kunert-Keil, F. Bisping, J. Kruger, and H. Brinkmeier, BMC Genomics, 7: 159 (2006); doi:10.1186/1471-2164-7-159.
8. Y. Higashi, T. Kiuchi, and K. Furuta. Clin. Ther., 32, No. 1: 34 (2010); doi: 10.1016/j.clinthera.2010.01.016.
9. C. Li, J. Li , X. Xiong, Y. Liu, and et al., Gene, 641: 111 (2018); doi: 10.1016/j.gene.2017.10.045.
10. C. D. Johnson, D. Melanaphy, A. Purse, S. A. Stokesberry, P. Dickson, and A. V. Zholos. Am. J. Physiol. Heart Circ. Physiol., 296: H1868 (2009), doi: 10.1152/ajpheart.01112.2008.
11. X.-P. Wang, X. Yu, X.-J. Yan, F. Lei, Y.-S. Chai, J.-F. Jiang, Z.-Y. Yuan, D.-M. Xing, and L.-J. Du, Scientific Reports, 7: 45155 (2017); doi: 10.1038/srep45155.
12. Jd. Souza and C. Gottfried, J. Electromyogr. Kinesiol., 23, No. 6: 1253 (2013); doi: 10.1016/j.jelekin.2013.07.009.
13. O. M. Khoma, D. A. Zavodovskyi, D. N. Nozdrenko, O. V. Dolhopolov, M. S. Miroshnychenko, and O. P. Motuziuk, Fiziol. Zh., 60, No. 1: 34 (2014).
14. D. N. Nozdrenko, S. M. Berehovyi, N. S. Nikitina, T. V. Beregova, and L. I. Ostapchenko, Biomed. Research., 29, No. 19: 3629 (2018).
15. A. Golub, O. Matyshevska, S. Prylutska, V. Sysoyev, L. Ped, V. Kudrenko, E. Radchenko, Yu. Prylutskyy, P. Scharff, and T. Braun, J. Mol. Liq., 105, Nos. 23: 141 (2003).
16. P. Scharff, U. Ritter, O. P. Matyshevska, S. V. Prylutska, I. I. Grynyuk, A. A. Golub, Yu. I. Prylutskyy, and A. P. Burlaka, Tumori, 94, No. 2: 278 (2008).
17. V. V. Turov, V. F. Chehun, T. V. Krupskaya, V. N. Barvinchenko, S. V. Chehun, A. P. Ugnichenko, Yu. I. Prylutskyy, P. Scharff, and U. Ritter, Phys. Lett., 496, Nos. 13: 152 (2010).
18. U. Ritter, Yu. I. Prylutskyy, M. P. Evstigneev, N. A. Davidenko, V. V. Cherepanov, A. I. Senenko, O. A. Marchenko, and A. G. Naumovets, Fullerenes, Nanotubes, Carbon Nanostruct., 23, No. 6: 530 (2015).
19. M. Tolkachov, V. Sokolova, V. Korolovych, Yu. Prylutskyy, M. Epple, U. Ritter, and P. Scharff, Mat.-wiss. u. Werkstofftech., 47, Nos. 23: 216 (2016).
20. S. V. Prylutska, A. G. Grebinyk, O. V. Lynchak, I. V. Byelinska, V. V. Cherepanov, E. Tauscher, O. P. Matyshevska, Yu. I. Prylutskyy, V. K. Rybalchenko, U. Ritter, and M. Frohme, Fullerenes, Nanotubes, Carbon Nanostruct., 27, No. 9: 715 (2019).
21. T. Hurme, H. Kalimo, M. Lehto, and M. Jarvinen, Med. Sci. Sports Exerc., 23, No. 7: 801 (1991).
22. D. M. Nozdrenko, D. O. Zavodovsky, T. Yu. Matvienko, S. Yu. Zay, K. I. Bogutska, Yu. I. Prylutskyy, U. Ritter, and P. Scharff, Nanoscale Res. Lett., 12, No. 115 (2017); doi: 10.1186/s11671-017-1876-4.
23. I. V. Vereshchaka, N. V. Bulgakova, A. V. Maznychenko, O. O. Gonchar, Yu. I. Prylutskyy, U. Ritter, W. Moska, T. Tomiak, D. M. Nozdrenko, I. V. Mishchenko, and A. I. Kostyukov, Front. Physiol., 9: 517 (2018); doi: 10.3389/fphys.2018.00517.
24. O. O. Gonchar, A. V. Maznychenko, N. V. Bulgakova, I. V. Vereshchaka, T. Tomiak, U. Ritter, Yu. I. Prylutskyy, I. M. Mankovska, and A. I. Kostyukov, Oxidative Med. Cell. Longevity, 2018, Article ID 2518676 (2018).
25. D. Julius, Annu. Rev. Cell Dev. Biol., 29: 355 (2013); doi: 10.1146/annurevcell-bio-101011-155833.
26. N. G. Versey, S. L. Halson, and B. T. Dawson, Sports Med., 43, No. 11: 1101 (2013); doi: 10.1007/s40279-013-0063-8.
27. L. A. Roberts, T. Raastad, J. F. Markworth, V. C. Figueiredo, I. M. Egner, A. Shield, D. Cameron-Smith, J. S. Coombes, and J. M. Peake, J. Physiol., 593, No. 18: 4285 (2015); doi: 10.1113/JP270570.
28. W. Gregson, R. Allan, S. Holden, P. Phibbs, D. Doran, I. Campbell, S. Waldron, C. H. Joo, and J. Morton, Med. Sci. Sports Exerc., 45: 1174 (2013); doi: 10.1249/MSS.0b013e3182814462.
29. H. Lee, H. Natsui, T. Akimoto, K. Yanagi, N. Oshshima, and I. Kono, Med. Sci. Sports Exerc., 37, No. 7: 1093 (2005); doi: 10.1249/01.mss.0000169611.21671.2e.
30. R. Topp, L. Winchester, A. M. Mink, J. S. Kaufman, and D. E. Jacks, J. Sport Rehabil., 20, No. 3: 355 (2011).
31. Y. Higashi, T. Kiuchi, and K. Furuta, Clin. Ther., 32, No. 1: 34 (2010); doi: 10.1016/j.clinthera.2010.01.016.
32. J. W. Isbary and H. Zeller, Fortschr. Med., 101, No. 29: 1351 (1983).
33. T. Nakayama, M. Fujita, and M. Ishihara, J. Surg. Res., 188, No. 1: 250 (2014).
34. A. Zholos, C. Johnson, T. Burdyga, and D. Melanaphy, Adv. Exp. Med. Biol., 704: 707 (2011); doi: 10.1007/978-94-007-0265-3_37.
Creative Commons License
This article is licensed under the Creative Commons Attribution-NoDerivatives 4.0 International License
©2003—2021 NANOSISTEMI, NANOMATERIALI, NANOTEHNOLOGII G. V. Kurdyumov Institute for Metal Physics of the National Academy of Sciences of Ukraine.

E-mail: tatar@imp.kiev.ua Phones and address of the editorial office About the collection User agreement